STPG2 antisense RNA 1 (non-protein coding) (STPG2-AS1)

STPG2 antisense RNA 1 (STPG2-AS1) is a long non-coding RNA (lncRNA) classified as a natural antisense transcript (NAT) that overlaps with and is transcribed from the opposite DNA strand of the STPG2 gene locus and does not encode a protein[4][5]. Like other antisense RNAs, it functions primarily in the regulation of gene expression, potentially by mechanisms such as transcriptional interference, chromatin remodeling, and epigenetic modification—common attributes of NATs[1][3]. There is currently no evidence in the biomedical literature or curated databases that STPG2-AS1 itself is a well-characterized therapeutic target, protein, enzyme, transporter, or receptor, nor are there any drugs known to directly interact with it[4][5]. No disease associations or roles have been robustly documented for STPG2-AS1 specifically as of the latest gene records[4][5]. Key context: - STPG2-AS1 is a non-coding transcript, part of the molecular family of long non-coding RNAs that regulate gene expression at transcriptional and possibly post-transcriptional levels[1][3][4]. - Antisense RNAs can impact gene expression in cis (locally) or trans (at distant sites), and can modulate chromatin state, recruit protein complexes, or regulate splicing[1][3]. - GeneCards and NCBI gene entries confirm that STPG2-AS1 is annotated in the human genome but do not link it to specific biological pathways, diseases, or pharmacological agents[4][5]. If more specific functional or disease-association data are published in future research, those would need to be reviewed for accurate classification of its biological and therapeutic relevance.

Other names

STPG2-AS1STPG2 antisense RNA 1STPG2 antisense RNA 1 (non-protein coding)